A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectiveness
- 29 July 2006
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 92 (5) , 585-588
- https://doi.org/10.1111/j.1365-2133.1975.tb03129.x
Abstract
A new formulation of hydrocortisone with vasoconstrictor activity has been shown to be effective clinically and was more effective in a 0.1% concentration than 1.0% Hydrocortisone Cream BPC. Its use should obviate the adverse effects of fluorinated steroids.Keywords
This publication has 13 references indexed in Scilit:
- A clinical trial with hydrocortisone butyrate cream in eczemaBritish Journal of Dermatology, 2006
- Double blind controlled study of treatment of atopic eczema with a preparation of hydrocortisone in a new drug delivery system versus betamethasone 17-valerateBritish Journal of Dermatology, 1974
- Pituitary-adrenal function after prolonged use of topical corticosteroidsBritish Journal of Dermatology, 1973
- THE IN VITRO PENETRATION OF FLUOCINONIDE THROUGH HUMAN SKIN FROM DIFFERENT VOLUMES OF DMSOBritish Journal of Dermatology, 1971
- The in Vivo Catabolism of Cortisol by Human Skin**From the Rheumatism Research Unit, Nether Edge Hospital, Sheffield, 11, England.Journal of Investigative Dermatology, 1971
- Adverse Effect of Topical Fluorinated Corticosteroids in RosaceaBMJ, 1969
- Tinea IncognitoBMJ, 1968
- THE ROLE OF VEHICLES IN THE PERCUTANEOUS ABSORPTION OF CORTICOSTEROIDS..British Journal of Dermatology, 1965
- Atrophic Striae in Patients with Inguinal IntertrigoArchives of Dermatology, 1963
- Method for Comparing Percutaneous Absorption of SteroidsArchives of Dermatology, 1962